Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Increased funding is needed to eliminate malaria across 22 Asia-Pacific countries and save an estimated 400,000 lives, according to research published in a new collection of studies on Wellcome Open Research.

Child writing on a blackboard © MORU 2019. Photographer: Nicky Almasy
A Cambodian child teaches his classmates what he's learned about malaria control, part of MORU's activities to raise community awareness in malaria-endemic areas of the importance of malaria prevention and the importance of early treatment. (c) MORU 2019. Photographer: Nicky Almasy.

Although Asia-Pacific countries have made significant progress towards their goal of eliminating malaria by 2030, collection researchers warn that stagnating donor funding puts at risk national malaria control efforts and access to lifesaving drugs and other tools, and could, under one potential scenario, result in as many as 845 million more malaria cases and 3.5 million deaths.

“This evidence-based investment case for the region comes from preliminary estimates to quantify the economic benefits of eliminating malaria, which could save hundreds of thousands of lives, avoid millions of malaria cases, and generate billions in healthcare savings, as well as savings from lost wages and productivity due to illness.” said collection advisor and study author Prof Richard Maude from the Mahidol Oxford Tropical Medicine Research Unit (MORU) in Bangkok.

“While the cost of eliminating malaria in the Asia Pacific is not insignificant, it will result in a large return on investment. For every additional dollar spent, there was predicted to be an overall economic benefit of USD $6 for the affected countries,” said lead study author Rima Shretta.

Read more (Nuffield Department of Medicine, Centre for Tropical Medicine & Global Health website)

Similar stories

Cancer Research UK to invest £11 million into cancer science in Oxford

A £11 million Cancer Research UK investment has been awarded to the University of Oxford and Oxford-based NHS to catalyse the translation of its world-leading cancer research for patient benefit.

Review highlights risk factors associated with violence in schizophrenia

Researchers at Oxford University’s Department of Psychiatry have found that people with schizophrenia and related disorders are at higher-than-average risk of perpetrating violence, but that the overall risk remains low (less than 1 in 20 in women, and less than 1 in 4 for men over a 35-year period for violent arrests and crimes).

An estimated 1.2 million people died in 2019 from antibiotic-resistant bacterial infections

First comprehensive analysis of global impact of antimicrobial resistance (AMR) estimates resistance itself caused 1.27 million deaths in 2019 - more deaths than HIV/AIDS or malaria - and that antimicrobial-resistant infections played a role in 4.95 million deaths.

Attention and memory deficits persist for months after recovery from mild Covid

Researchers from Oxford’s Department of Experimental Psychology and Nuffield Department of Clinical Neurosciences have shown that people who have had Covid but don’t complain of long Covid symptoms in daily life nevertheless can show degraded attention and memory for up to 6-9 months.

Plaster cast or metal pins to treat a broken wrist? The results are in.

An Oxford study published in The BMJ has found the use of metal K-wires (commonly known as ‘pins’) to hold broken wrist bones in place while they heal are no better than a traditional moulded plaster cast.

New book expands the horizons of brain research

A pioneering book from Professor Zoltán Molnár and Yale Professors Tamas Horvath and Joy Hirsch to be released on 1 February 2022 addresses the fundamental relationship between the body, brain and behaviour.